Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00415896|
Recruitment Status : Unknown
Verified December 2006 by Krankenhaus Kloster Grafschaft.
Recruitment status was: Recruiting
First Posted : December 25, 2006
Last Update Posted : December 25, 2006
|Condition or disease||Intervention/treatment||Phase|
|Chronic Respiratory Failure||Device: positive pressure ventilation||Not Applicable|
Liberation from mechanical ventilation in difficult to wean patients is best accomplished by intermittent spontaneous breathing trials (1). Optimal respiratory muscle rest in-between breathing trials however has never been investigated.
Using a crossover design, patients are to be ventilated with complete and partial respiratory muscle unloading for a period of ten hours respectively. Respiratory muscle activity is being monitored by oesophageal balloon technique using a commercially available System (Avea, Viasys, Conshohocken, PA, USA). Time of spontaneous breathing, respiratory- and ABG parameters are being determined to characterize the course of each spontaneous breathing trial.
1. Esteban, A., F. Frutos, M. J. Tobin, I. Alia, J. F. Solsona, I. Valverdu, R. Fernandez, M. A. de la Cal, S. Benito, R. Tomas, and et al. 1995. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 332(6):345-50.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||10 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance|
|Study Start Date :||December 2006|
|Study Completion Date :||June 2007|
- Endurance time
- PCO2, respiratory parameters
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00415896
|Contact: Dominic Dellweg, M.D.||+49 2972 791 ext firstname.lastname@example.org|
|Contact: Dieter Koehler, M.D. Prof.||+40 2972 791 ext email@example.com|
|Schmallenberg, Annostr. 1, Germany, 57392|
|Contact: Dominic Dellweg, M.D. +49 2972 791 ext 1257 firstname.lastname@example.org|
|Contact: Dieter Koehler, M.D. Prof. +49 2972 791 ext 2500 email@example.com|
|Sub-Investigator: Stefan Boeckling|
|Principal Investigator:||Dominic Dellweg, M.D.||FKKG|
|Study Chair:||Dieter Koehler, M.D., Prof.||FKKG|